Ardelyx
ARDX • NASDAQ
Ardelyx is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael G. Raab, with a market cap of $1.5B.
Market Cap$1.5B
Employees267.0
CEOMichael G. Raab
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 30, 2026 · In 2 weeksQ1 2026
Financials
Ardelyx FAQ
Common questions about Ardelyx
Ardelyx is scheduled to report earnings for Q1 2026 on April 30, 2026. Analysts estimate revenue of $95.2M.
Ardelyx has approximately 267 employees.